EMINENCE CAPITAL, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMINENCE CAPITAL, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$84,445,000
+153.3%
847,328
+192.0%
0.92%
+146.4%
Q4 2019$33,337,000
-11.5%
290,140
-2.9%
0.38%
-17.4%
Q3 2019$37,679,000
-64.4%
298,706
-66.1%
0.45%
-67.5%
Q2 2019$105,926,000
+987.4%
880,219
+690.5%
1.40%
+864.1%
Q1 2019$9,741,000111,3560.14%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders